Depression ,Anxiety and Stress Disorders Among Diabetic Patients in Assuit University Hospitals
Depression, Anxiety and Stress Disorders Among Diabetic Patients in Assuit University Hospitals
1 other identifier
observational
325
0 countries
N/A
Brief Summary
- 1.Assessment the prevalence of psychiatric disorders in diabetic patient in Assuit University Hospital.
- 2.Determine the associated factors with the psychiatric disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2023
CompletedFirst Posted
Study publicly available on registry
October 6, 2023
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 28, 2024
February 1, 2024
8 months
September 30, 2023
February 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Depression ,Anxiety and stress disorders among diabetic patients in Assuit University Hospitals.
1. Assessment the prevalence of psychiatric disorders in diabetic patient in Assuit University Hospital. 2. Determine the associated factors with the psychiatric disorders.
Baseline
Eligibility Criteria
Type 1 diabetes is a lifelong autoimmune disease characterized by insulin deficiency and resultant hyperglycemia. It constitutes around 10% of all diagnosed cases of diabetes and its incidence is increasing globally. Type 2 diabetes mellitus (DM2) is a chronic metabolic disease characterized by an increase in normal serum glucose levels (hyperglycemia).
You may qualify if:
- Age between 18 and 70 years Diagnosed according to criteria of the American Diabetes Association fasting plasma glucose (FPG) level of 126 mg/dL (7.0 mmol/L) or higher or A 2-hour plasma glucose level of 200 mg/dL (11.1 mmol/L) or higher during a 75-g oral glucose tolerance test (OGTT).
You may not qualify if:
- Patient with cognitive difficulties
- To be very sick and unable to give consent
- Women who were pregnant or had given birth in the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor
Study Record Dates
First Submitted
September 30, 2023
First Posted
October 6, 2023
Study Start
April 1, 2024
Primary Completion
November 30, 2024
Study Completion
December 31, 2024
Last Updated
February 28, 2024
Record last verified: 2024-02